APA (7th ed.) Citation

JC, P., MV, C., JE, C., IB, F., DM, G., DB, H., . . . JE, W. (2009). Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): An orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R). Journal of medicinal chemistry, 52(7), 2148. https://doi.org/10.1021/jm801572m

Chicago Style (17th ed.) Citation

JC, Pelletier, et al. "Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): An Orally Active Antagonist of the Gonadotropin Releasing Hormone Receptor (GnRH-R)." Journal of Medicinal Chemistry 52, no. 7 (2009): 2148. https://doi.org/10.1021/jm801572m.

MLA (9th ed.) Citation

JC, Pelletier, et al. "Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): An Orally Active Antagonist of the Gonadotropin Releasing Hormone Receptor (GnRH-R)." Journal of Medicinal Chemistry, vol. 52, no. 7, 2009, p. 2148, https://doi.org/10.1021/jm801572m.